SCHEMBL3635924

SCHEMBL3635924

NCC(Cn1ccc(=O)[nH]c1=O)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
DUT P33316 10/20 0.57
PKM P14618 1/20 0.50
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA9 Q16790 1/20 0.40
CRBN Q96SW2 2/20 0.40
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(S)-Willardiine SCHEMBL401191 0.81 GRIA1 (0.56) DUTPKMALDH1A1LMNAKDM4E
(S)-Willardiine SCHEMBL438494 0.81 GRIA1 (0.56) DUTPKMALDH1A1LMNAKDM4E
SCHEMBL7136481 0.78 PKM (0.56) DUTPKMALDH1A1LMNACRBN
SCHEMBL17016484 0.78 DUT (0.51) DUTPKM
SCHEMBL5001166 0.76 DUT (0.51) DUTPKMALDH1A1LMNACA1
SCHEMBL23873265 0.75 PKM (0.60) DUTPKMALDH1A1LMNACRBN
SCHEMBL4311546 0.75 DUT (0.50) DUTPKMALDH1A1LMNACA1
SCHEMBL5000786 0.75 DUT (0.50) DUTPKMALDH1A1LMNACA1
SCHEMBL6102943 0.74 CRBN (0.56) DUTPKMALDH1A1LMNACA1
SCHEMBL666953 0.74 GRM5 (0.50) DUTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023174398-A1 SYNTHETIC TUMOR-INFILTRATING LYMPHOCYTES (TILS) ROOTPATH , INC. (KY) 2023-09-21 WO disclosed
EP-4176076-A1 METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA The Johns Hopkins University (US) 2023-05-10 EP disclosed
EP-3953475-A1 NUCLEIC ACID MAZZOCCHIO AND METHODS OF MAKING AND USE THEREOF The University of Hong Kong (CN) 2022-02-16 EP disclosed
WO-2022000399-A1 METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA THE JOHNS HOPKINS UNIVERSITY (US) 2022-01-06 WO disclosed
EP-3906325-A1 COMPOSITIONS AND METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS Hangzhou New Horizon Health Technology Co., Ltd. (CN) 2021-11-10 EP disclosed
WO-2020252721-A1 DNA METHYLATION MARKERS AND THEIR USE IN DIFFERENTIATION OF SUSPECTED CANCEROUS LYMPH NODE BIOPSY SAMPLES THE JOHNS HOPKINS UNIVERSITY (US) 2020-12-24 WO disclosed
WO-2020239144-A1 SYNTHESIS OF TRANSCRIPTS USING VSW-3 RNA POLYMERASE RNASYN BIOTECH. CO., LTD. (CN) 2020-12-03 WO disclosed
WO-2020207420-A1 NUCLEIC ACID MAZZOCCHIO AND METHODS OF MAKING AND USE THEREOF THE UNIVERSITY OF HONG KONG (CN) 2020-10-15 WO disclosed
WO-2020140974-A1 COMPOSITIONS AND METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS HANGZHOU NEW HORIZON HEALTH TECHNOLOGY CO. LTD. (CN) 2020-07-09 WO disclosed
CN-104822705-B M971 Chimeric antigen receptor 美国卫生和人力服务部 2019-07-12 CN disclosed
US-20060105974-A1 Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy ECOLE POLYTECHNIQUE FEDERAL DE LAUSANNE (CH) 2006-05-18 US disclosed
WO-2004004769-A1 CONJUGATES OF PHOTOSENSITIZERS AND OLIGONUCLEOTIDES FOR SELECTIVE PHOTOCHEMIOTHERAPY ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) 2004-01-15 WO disclosed
EP-1358348-A2 COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF PSORIASIS Genetics Institute, LLC (US) 2003-11-05 EP disclosed
WO-2003025010-A2 HUMAN DELTA-N P73 MOLECULES AND USES THEREOF EIRX THERAPEUTICS LIMITED (IE) 2003-03-27 WO disclosed
EP-1290227-A1 COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION AND MODULATION OF TYPE I DIABETES Genetics Institute, LLC (US) 2003-03-12 EP disclosed
EP-1263791-A2 HUMAN G-PROTEIN CHEMOKINE RECEPTOR (CCR5) HDGNR10 Human Genome Sciences, Inc. (US) 2002-12-11 EP disclosed
WO-2001094636-A2 COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION AND MODULATION OF TYPE I DIABETES GENETICS INST (US) 2001-12-13 WO disclosed
WO-2001086002-A2 COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF PSORIASIS GENETICS INSTITUTE, LLC (US) 2001-11-15 WO disclosed
WO-2001058916-A2 ANTIBODIES TO CCR5 HUMAN GENOME SCIENCES, INC. (US) 2001-08-16 WO disclosed
WO-1998025630-A1 TRANSALDOLASE-MEDIATED REGULATION OF APOPTOSIS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1998-06-18 WO disclosed